Concepedia

Makoto Oka

MO

Statistics

Publications

13

Citations

406

H-Index

12

Active since

1975

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Makoto Oka is an author at Sumitomo Dainippon Pharma (Japan) specializing in neuropharmacology, pharmacology, and medicine.

Publications per year

1975–2004

13

Publications

13

Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand

Atsuko Kita, Hitoshi Kohayakawa, Tomoko Kinoshita et al. · British Journal of Pharmacology · 2004 · 128 citations · Full text

, , +14

Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.

Makoto Oka, Yasutaka Noda, Y Ochi et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 55 citations · Full text

, , +17

A novel class of antiulcer agents. 4-Phenyl-2-(1-piperazinyl)quinolines.

Katsuhiko Hino, Katsuyoshi Kawashima, Makoto Oka et al. · Chemical and Pharmaceutical Bulletin · 1989 · 32 citations · Full text

, , +9

Effects of Antidepressant Drugs on Amygdaloid After-Discharge in Rats

Chiaki Kamei, Yoshinobu Masuda, Makoto Oka et al. · The Japanese Journal of Pharmacology · 1975 · 30 citations · Full text

, , +16

A novel class of potential central nervous system agents. 3-Phenyl-2-(1-piperazinyl)-5H-1-benzazepines

Katsuhiko Hino, Yasutaka Nagai, Hitoshi Uno et al. · Journal of Medicinal Chemistry · 1988 · 26 citations

, , +5

1–5 of 13